Summary of the combinations of tumor cells and sera used for mapping the serospecificities of cutaneous lymphoma patients by 2-dimensional electrophoresis and proteome analyses.

†The tumor cells used for the 2-dimensional electrophoreses were either the mycosis fungoides tumor cell line MyLa or tumor cells freshly isolated from tumor lesion of the indicated patients.
‡The sera used to identify tumor-associated antigens by 2-dimensional Western blot analyses were obtained from patients with cutaneous lymphoma. For the heterogeneous combinations of sera and tumor cells, 8 independent sera each were grouped into two Western blot experiments. In 2 cases single sera were analyzed. The Western blots A–D are shown in Figure 2.
*The numbering of the sera in this summary is the same as indicated in Figure 1 for the 1-dimensional Western blot analyses and Figures 2–4 for the 2-dimensional analyses.
#The numbers given for the antigens refer to the indicated Western blot analyses. Some antigens were identified repeatedly for different tumor cells and patients.